Invests at least 80% of its net assets in U.S. equity securities. Targets pioneering American companies that are developing novel products, services, or technologies. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 29% a year over the last 4 years. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 4 years, sales grew about 29% a year on average.
Sales run at $418.4M a year. A small number, but proof the product has real buyers.
It pays out $0.06 per share each year — regular cash for whoever holds the stock.
A loss of $21.2M against $418.4M in annual sales.
The price action doesn’t yet back an upward turn. Council score: 3/10.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.